SEARCH NEWS & VIEWS


From Curiosity to Click Chemistry: K. Barry Sharpless Forges His Own Way
Scripps Research Appoints Noted Autism Researcher to Neuroscience Faculty
Snapshot: Andrea Zuhl

NEWS & VIEWS HOME
PAST ISSUES
KUDOS
SCIENTIFIC CALENDAR
CA AUDITORIUM EVENTS
CONTACT




FOLLOW US

Scripps Research Appoints Noted Autism Researcher to Neuroscience Faculty

By Eric Sauter

The Scripps Research Institute has appointed Damon Page as assistant professor in the Department of Neuroscience.

Page, 36, will work on the Scripps Florida campus in Jupiter. Prior to his appointment, he was a senior analyst at the Allen Institute for Brain Science in Seattle, Washington.

“Damon’s research on autism makes a valuable addition to our department,” said Ron L. Davis, chair of the Department of Neuroscience. “His discovery of genes that can cause autism-like symptoms is a breakthrough in the complex origins of the disease and offers new potential therapeutic targets to investigate. We’re delighted he is joining us.”

“This is a wonderful opportunity to be part of a dynamic, highly collaborative organization, with a breadth of basic and translational research that meshes perfectly with my research,” Page said. “Scripps Florida is a unique place to explore the basic science of how the brain develops and then to use that knowledge to develop potential new treatments for autism.”

Page, who lives in Jupiter, received his bachelor’s degree in biology from Eastern Oregon University in 1999 and his PhD from the University of Cambridge in 2002. He was a postdoctoral fellow at the MRC Laboratory of Molecular Biology from 2002 to 2004 and the Massachusetts Institute of Technology (MIT) from 2004 to 2009; he worked as a research scientist at MIT from 2009 to 2010.

It was during his stint at MIT that Page led a groundbreaking study that resulted in the discovery of a novel mechanism whereby two autism risk factors interact to shape autism-like symptoms in an animal model. That discovery showed for the first time that genes acting in two distinct molecular pathways implicated in autism can interact to significantly influence the severity of symptoms. The study pointed to the intersection of these pathways as a potential new target for therapeutic development.

Autism is a complex neurodevelopmental disorder that impairs the normal development of social and communication skills, among other facilities. Autism is the most severe form of autism spectrum disorders; milder forms include Asperger syndrome. According to the National Institutes of Health, six children out of every 1,000 have autism spectrum disorder, with males four times more likely to be afflicted than females.

“There are a number of risk factors for autism,” Page said, “but at present we don’t understand how these interact in the developing brain to cause the disorder. My aim is to shed light on this problem, but, more importantly, to apply what we learn in the laboratory to help individuals and families affected by the disorder.”

For more information, see Page’s faculty web page at http://www.scripps.edu/research/faculty/page.

 

 

 





Send comments to: press@scripps.edu



page
“My aim is to shed light on [autism and] to apply what we learn in the laboratory to help individuals and families affected by the disorder,” says Assistant Professor Damon Page. (Photo by James McEntee.)